Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Electrophoresis|August 5, 2006
Dialysis-assisted two-dimensional gel electrophoresisOlivier Danos, Fedor Svinartchouk
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysatesJerome Denard, Christine Jenny, Véronique Blouin, et al.
Neuromuscular Disorders : NMD|February 3, 2009
Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: a pilot studyBelaid Bouazza, Gueorgui Kratassiouk, Bernard Gjata, et al.
Proteomics|July 30, 2009
Quantitative proteomic analysis of lentiviral vectors using 2-DEJérôme Denard, Stéphanie Rundwasser, Nicolas Laroudie, et al.
Neuromuscular Disorders : NMD|May 13, 2014
Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophyJeremy Rouillon, Aleksandar Zocevic, Thibaut Leger, et al.
Human Molecular Genetics|March 24, 2017
AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expressionEvelyne Gicquel, Natacha Maizonnier, Steven J Foltz, et al.
Molecular Therapy. Nucleic Acids|December 28, 2019
Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping TherapyPhilippine Aupy, Lucía Echevarría, Karima Relizani, et al.
Molecular Therapy. Methods & Clinical Development|August 30, 2018
AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6Jérôme Denard, Jérémy Rouillon, Thibaut Leger, et al.
Nucleic Acid Therapeutics|April 23, 2019
Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse ModelLucía Echevarría, Philippine Aupy, Karima Relizani, et al.
Pageof 2